RELMADA THERAPEUTICS, INC. (RLMD) Capital expenditures 2016–2020
RELMADA THERAPEUTICS, INC. (RLMD) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$182.1MFY2020 · since FY2016: $49,690 → $182.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $182.1M | +114.6% |
| FY2019 | $84.8M | — |
| FY2017 | $12,391 | -75.1% |
| FY2016 | $49,690 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice